Qualigens Pharma Private Limited
↗Mumbai, India
Qualigens Pharma is an Indian pharmaceutical company specializing in the manufacturing of high-volume generic pharmaceutical formulations, including tablets and capsules. Founded in 2013, the company operates a state-of-the-art, fully integrated manufacturing facility located in Khopoli, near Mumbai, designed to meet both domestic and international quality standards.
The company focuses on providing contract manufacturing and supply services to global partners. Their facility is accredited by several regulatory bodies, including EU-GMP and SAHPRA, enabling them to produce and distribute quality-assured generic and branded products with a focus on efficacy, safety, and compliance.
CLASSIFICATION
Company Type:CDMO
Therapeutic Areas:-
Industry:Pharmaceuticals
Sub-Industry:CDMO / Generic Manufacturing
SIZE & FINANCIALS
Employees:201-500
Revenue:$25M-$30M
Founded:2013
Ownership:private
Status:operating
FUNDING
Total Raised:$0
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Global pharmaceutical partners for contract manufacturing
COMPETITION
Position:Niche Player
Competitors:Merck, Roivant Sciences, Recursion Pharmaceuticals
LEADERSHIP
Key Executives:
Ajit Jain - Director
Ankit Suresh Paharia - Director
Aayush Jain - Director
LINKS
Website:qualigenspharma.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Qualigens Pharma Private Limited and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Qualigens Pharma Private Limited. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.